Skip to main content
. 2018 Oct 15;9:2308. doi: 10.3389/fimmu.2018.02308

Table 1.

An overview in mouse of the contribution of the iNKT cell/IL-33 biological axis during acute sterile inflammation.

Reference(s) Model Organ Role of iNKT cells Mode of action of iNKT cells Role of IL-33 iNKT cell/IL-33 axis
Ferhat et al. (7)
Li et al. (8)
IRI Kidney initiation (7, 8)
Jα18 KO mice
IFN-γ, IL-17
CD1d-dependent
Initiation (7)
IL-33 KO mice
ST2 KO mice
IL-33-dependent iNKT cell
recruitment/activation (7)
Lappas et al. (11)
Arrenberg et al. (12) Richards et al. (16) Kuboki et al. (17) Yazdani et al. (18)
IRI Liver initiation (11, 12, 16, 17)
NK1.1 depletion
iNKT-cell adoptive
transfer
IFN-γ, IL-17
CD1d-dependent
Initiation (18)
IL-33 KO mice
Presumably yes
Arshad et al. (19)
Arshad et al. (20)
ConA-induced injury Liver initiation (19, 20)
iNKT-cell adoptive
transfer
IL-4, IFN-γ Resolution (20) iNKT-cell-dependent
regulation of IL-33
expression by hepatocytes
Cao et al. (21) IRI Liver resolution (21)
by iNKT-cell-targeted
therapy (α-GalCer)
IL-13
A2AR
Unknown Unpredictable
Lappas et al. (11) IRI Liver resolution (11)
by iNKT-cell-targeted
therapy (A2AR agonist)
IFN-γ ↓ unknown Presumably not
Cheng et al. (22)
Antunes et al. (23)
Drug-induced injury Liver initiation (22)
CD1d KO mice
Not done Initiation (23)
ST2 KO mice
Presumably yes
Liew et al. (24) Thermal injury Liver resolution (24)
iNKT-cell adoptive
transfer
IL-4 Unknown Unpredictable
Sharma et al. (13, 25) IRI Lung initiation (13, 25)
Jα18 KO mice
iNKT-cell adoptive
transfer
NOX-2
IL-17
Unknown Unpredictable
Sharma et al. (25) IRI Lung resolution (25)
by iNKT-cell-targeted
therapy (A2AR agonist)
NOX-2 ↓
ê IL-17 ↓
Unknown Unpredictable
Grabarz et al. (26)
Kim et al. (27) Bourgeois et al. (28) Li et al. (29)
Luzina et al. (30)
Bleomycin-induced fibrosis Lung resolution (26, 27) IFN-γ Initiation (29, 30) Presumably yes (28)
Michaudel et al. (31)
Pichavant et al. (32)
Kubala et al. (33)
Ozone-induced fibrosis Lung initiation (32)
Jα18 KO mice
IL-17 Initiation (31, 33)
resolution (31)
IL-33 KO mice
Presumably yes (32)
presumably not

This table recapitulates the main models of acute sterile inflammation, especially IRI models, that involve iNKT cells in different target organs (kidney, liver, and lung). In parallel, when documented, the involvement of IL-33 is indicated; otherwise it is noted as unknown. The implication(s) of iNKT cells and/or IL-33 has (have) been classified according to their contribution to the initiation and/or resolution phase(s) of sterile inflammation, and accompanied by the relevant bibliography. The mode(s) of action of iNKT cells is (are) specified. In the last column, using the cited bibliography, the existence of an iNKT cell/IL-33 axis is shown, surmised (noted ≪ presumably yes ≫) not surmised (noted ≪ presumably not ≫) or difficult to predict (noted ≪ unpredictable ≫). IRI, Ischemia-Reperfusion injury; A2AR, adenosine A2A receptor; α-GalCer, α-galactosylceramide; iNKT, invariant Natural Killer T; KO, transgenic knockout; IFN, interferon; IL, interleukin; NOX-2, NADPH oxidase 2; ↓, decrease.